Production (Stage)
Spectral Medical Inc.
EDT.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.06% | 40.94% | 11.57% | 7.63% | -0.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.06% | 40.94% | 11.57% | 7.63% | -0.41% |
| Cost of Revenue | 3.96% | 43.24% | 44.86% | 62.73% | 68.07% |
| Gross Profit | 59.83% | 37.64% | -21.66% | -36.58% | -46.19% |
| SG&A Expenses | 10.79% | 4.85% | 15.09% | 18.37% | 39.39% |
| Depreciation & Amortization | 129.40% | 196.77% | 172.12% | 170.36% | 32.46% |
| Other Operating Expenses | -10.25% | -30.05% | -33.11% | 582.17% | 1,203.66% |
| Total Operating Expenses | 12.43% | 10.84% | 19.87% | 28.99% | 44.77% |
| Operating Income | -11.01% | -6.53% | -21.32% | -33.00% | -55.09% |
| Income Before Tax | -24.10% | 0.95% | -141.11% | -106.47% | -170.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.10% | 0.95% | -141.11% | -106.47% | -170.12% |
| Earnings from Discontinued Operations | 94.10% | 95.54% | 97.71% | 92.28% | 96.33% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.38% | 1.88% | -111.95% | -68.62% | -86.96% |
| EBIT | -11.01% | -6.53% | -21.32% | -33.00% | -55.09% |
| EBITDA | -11.01% | -6.49% | -22.06% | -33.96% | -57.09% |
| EPS Basic | -21.77% | 2.40% | -110.26% | -66.00% | -81.68% |
| Normalized Basic EPS | -26.85% | -2.83% | -138.10% | -100.00% | -159.13% |
| EPS Diluted | -21.77% | 2.40% | -110.26% | -66.00% | -81.68% |
| Normalized Diluted EPS | -26.85% | -2.83% | -138.10% | -100.00% | -159.13% |
| Average Basic Shares Outstanding | 1.33% | 0.94% | 0.82% | 1.48% | 2.32% |
| Average Diluted Shares Outstanding | 1.33% | 0.94% | 0.82% | 1.48% | 2.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |